British MP Jo Cox Murdered: Now Comes The Psyop

logic word
Source: NoMoreFakeNews.com
Jon Rappoport
June 17, 2016

(To read about Jon’s mega-collection, Power Outside The Matrix, click here.)

“Create a killer? Take someone who’s unstable, pump him up with SSRI antidepressants, fill his head full of ideas about violent action, point him in a desired direction, and stand back.” (The Underground, Jon Rappoport)

On June 23rd, the UK will vote on whether to stay in the European Union (the “remain” campaign) or leave the EU (“Brexit”).

The polls show a marked shift, with Brexit supporters gaining. Then a British MP, Jo Cox, who has urged Brits to remain, is murdered.

The man who is arrested, Thomas Mair, is alleged to have shouted “Britain First!” (Brexit) as he killed Cox. However, now witnesses on the scene are saying they heard no such thing.

Too late. Social media and news media are running with the “Britain First, Brexit killer” narrative.

Here is the psyop formula:

MP Jo Cox wanted to remain in the EU. Her killer was a “Brexit right-wing crazy” who yelled “Britain First!” as he murdered her. Therefore, all people who want Brexit are right-wing crazies. Therefore, vote to remain in the EU.

This is how you demonize millions of people.

Jo Cox=good=remain in the EU. Her killer=leave the EU=all people who want to leave the EU are killers.

And then there is this. The arrested killer, Thomas Mair, is widely acknowledged to have been mentally unstable. Well, read this local news story from several year ago, for yourself:

“Thomas Mair, 46, started volunteering at the park [creating a garden] after learning about the opportunity through the Mirfield-based Pathways Day Centre for adults with mental health problems.”

“He said: “I can honestly say it has done me more good than all the psychotherapy and medication in the world.”

“All these problems are alleviated by doing voluntary work.”

“Getting out of the house and meeting new people is a good thing, but more important in my view is doing physically demanding and useful labour.”

“When you have finished there is a feeling of achievement which is emotionally rewarding and psychologically fulfilling.”

Mair states he had been on medication. Specifically which drugs? SSRI antidepressants are a distinct possibility. If so, that’s a potential clue, because these drugs are known to push people over the edge into violent behavior, including suicide and homicide. The same violence can be generated by suddenly withdrawing from the drugs.

For example:

A shooting massacre at Columbine High School took place on April 20, 1999. Astonishingly, for eight days after the tragedy, during thousands of hours of prime-time television coverage, virtually no one mentioned the word “drugs.” Then the issue was opened. Eric Harris, one of the shooters at Columbine, was on at least one drug.

The NY Times of April 29, 1999, and other papers reported that Harris was rejected from enlisting in the Marines for medical reasons. A friend of the family told the Times that Harris was being treated by a psychiatrist. And then several sources told the Washington Post that the drug prescribed as treatment was Luvox, manufactured by Solvay.

In two more days, the “drug-issue” was gone.

Luvox is of the same class as Prozac and Zoloft and Paxil. They are labeled SSRIs (selective serotonin reuptake inhibitors). They attempt to alleviate depression by changing brain-levels of the natural substance serotonin. Luvox has a slightly different chemical configuration from Prozac, Paxil, and Zoloft, and it was approved by the FDA for obsessive-compulsive disorder, although many doctors apparently prescribed it for depression.

Continue Reading At: JonRappoport.wordpress.com

________________________________________________________________

Jon Rappoport

The author of three explosive collections, THE MATRIX REVEALED, EXIT FROM THE MATRIX, and POWER OUTSIDE THE MATRIX, Jon was a candidate for a US Congressional seat in the 29th District of California. He maintains a consulting practice for private clients, the purpose of which is the expansion of personal creative power. Nominated for a Pulitzer Prize, he has worked as an investigative reporter for 30 years, writing articles on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other newspapers and magazines in the US and Europe. Jon has delivered lectures and seminars on global politics, health, logic, and creative power to audiences around the world. You can sign up for his free NoMoreFakeNews emails here or his free OutsideTheRealityMachine emails here.

Should Paxil be banned? The only ‘evidence’ of effectiveness was ghostwritten by Glaxo Smith Kline’s public relations firm

Paxil

Source: NaturalNews.com
Amy Goodrich
March 29, 2016

In 2001, a study was published in the Journal of the American Academy of Child and Adolescent Psychiatry, showing that the SSRI antidepressant paroxetine – sold under the names Paxil, Aropax and Seroxat – was safe, well tolerated and effective for the treatment of depression, obsessive-compulsive disorder, post-traumatic stress disorder and social anxiety in adults and teenagers.

However, a recent reanalysis of the same data, published in the British Medical Journal (BMJ), reports that the opposite is true. It is the first reanalysis of a drug trial by a collaboration of researchers called RIAT (Restoring Invisible and Abandoned Trials). Their aim is to correct abandoned or misreported studies to ensure that doctors and patients are given the most accurate information.

Flawed research

The original study, known as Study 329, was authored by Dr. Martin Keller, et. al., but it was actually ghostwritten by Sally Laden, who was hired by the drug manufacturer Glaxo Smith Kline (GSK). Severe adverse effects of the drug were vaguely described and deliberately left out of the report. GSK used Study 329 to promote the use of Paxil in depressed teenagers.

While drug companies aren’t allowed to promote drugs for unapproved uses, doctors took the results for granted, and prescription of these unapproved drugs for off-label use skyrocketed over the years.

The drug brought in $11.6 billion between 1997 and 2006. By 2007, it was one of the most prescribed antidepressant drugs in the U.S., with more than 18 million annual prescriptions.

Suicidal thoughts and behavior

In the years after Study 329 was published, doctors and concerned parents worldwide reported signs of suicidal thoughts and behavior among teens who were prescribed paroxetine to treat depression. For years, small groups of patients and doctors have voiced their fears about SSRIs such as Paxil. However, many clinicians and drug companies disagreed, relying heavily on the findings published in Study 329.

In 2002, the U.S. Food and Drug Administration (FDA) was finally alarmed, and began researching the potential dangers. The results were clear, but instead of taking the drug off the market, they only advised doctors not to prescribe it to teens suffering from depression.

In 2004, an FDA panel voted that manufacturers be required to include a black box warning on every package. It should clearly state that taking Paxil or other SSRI drugs increases the risk of suicidal thinking and behavior in children, young adults and adolescents. The warning also states that anyone who takes SSRI’s to treat depression should be closely watched for significant changes in their behavior.

Despite rising concerns and evidence regarding the lack of safety and effectiveness, Study 329 lived on. It was never questioned, retracted or edited – until now.

Reanalysis reveals alarming results

After years of trying to access GSK’s data, researchers from the RIAT finally got their hands on more than 77,000 pages of patients’ information.

According to author Dr. Jon Jureidini, professor and research leader of critical and ethical mental health at the University of Adelaide, the authors of the original Study 329, “deliberately misrepresented the outcomes of the study,” and changed the protocols of the study without following the proper procedures to do so.

Continue Reading At: NaturalNews.com